Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Changes in Segmental Bioimpedance Following Eccentric Plantar Flexor Exercise Taken to Volitional Failure.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2026

Same author

Acute non-local effects on range of motion and drop jumping performance following static stretching of the knee extensors and knee flexors.

Journal of bodywork and movement therapies·2026

Same author

Cell Membrane Capacitance and Characteristic Frequency Among Youth and Adults: Reference Data From NHANES 1999-2000.

Journal of the American Nutrition Association·2026

Same author

Exploring the Gut Microbiome in Combat Sports: A Systematic Scoping Review.

Sports (Basel, Switzerland)·2026

Same author

Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study.

International journal of molecular sciences·2025

Same author

Application of the Performance Index for Monitoring Anaerobic Endurance of Competitive Swimmers.

Journal of human kinetics·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Lipid nanoparticles for brain targeting I. Formulation optimization.

Paolo Blasi¹, Stefano Giovagnoli, Aurélie Schoubben

¹Dipartimento di Chimica e Tecnologia del Farmaco, Università degli Studi di Perugia, via del Liceo 1, 06123 Perugia, Italy. kaolino@unipg.it

International Journal of Pharmaceutics

|August 11, 2011

Summary

This summary is machine-generated.

Researchers optimized lipid nanoparticles (NPs) for brain targeting using computer-aided design. Cetyl palmitate NPs achieved the smallest size, ideal for brain delivery applications.

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Area of Science:

Pharmaceutical Nanotechnology
Drug Delivery Systems
Biomedical Engineering

Background:

Developing effective drug delivery systems for brain targeting remains a significant challenge.
Lipid nanoparticles (NPs) offer potential for enhanced drug delivery due to their biocompatibility and ability to encapsulate various compounds.
Optimizing NP formulation is crucial for achieving desired characteristics like particle size and stability for specific applications.

Purpose of the Study:

To optimize the formulation of lipid nanoparticles (NPs) for brain targeting applications.
To investigate the suitability of different lipids (Softisan® 142, Compritol® 888 ATO, cetyl palmitate) for NP formulation.
To identify optimal preparation conditions using a computer-generated experimental design.

Main Methods:

Utilized high-pressure homogenization technique for formulating lipid nanoparticles.
Employed a computer-generated experimental design to efficiently determine optimal preparation parameters.
Investigated three distinct lipids: Softisan® 142 (SOFT), Compritol® 888 ATO (COMP), and cetyl palmitate (CP).

Main Results:

High-pressure homogenization successfully produced nanometre-sized lipid particles from all three investigated lipids.
The computer-generated experimental design significantly reduced the number of experimental assays required for optimization.
Cetyl palmitate (CP) NPs exhibited the smallest particle size and suitable thermal properties for brain targeting applications.
All optimized formulations demonstrated suitability for intravenous infusion.

Conclusions:

Computer-aided experimental design is an efficient tool for optimizing lipid nanoparticle formulations.
Cetyl palmitate-based lipid nanoparticles are a promising candidate for brain targeting due to their optimal particle size and thermal characteristics.
The developed lipid NPs are suitable for intravenous administration, paving the way for potential therapeutic applications in brain targeting.